Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) have been suggested to offer therapeutic benefit in patients with pulmonary arterial hypertension (PAH). We conducted two analyses to explore the association between SSRI use and PAH outcomes using the Registry to Evaluate Early and Long-te...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Sadoughi, Ali, Roberts, Kari E., Preston, Ioana R., Lai, Ginny P., McCollister, Deborah H., Farber, Harrison W., Hill, Nicholas S.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694099/
https://ncbi.nlm.nih.gov/pubmed/23558791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.12-2081
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados